SMTL ID : 6bbu.1

Crystal Structure of JAK1 in complex with compound 25

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.08 Å

Oligo State

monomer

Ligands

1 x D7D: N-{cis-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide(Non-covalent)

D7D.1: 22 residues within 4Å: Chain A: L.43, G.44, E.45, G.46, G.49, K.50, V.51, A.68, K.70, V.100, M.118, E.119, F.120, L.121, G.124, S.125, E.128, R.169, N.170, L.172, G.182, D.183 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.172 Hydrogen bonds: A:E.119, A:L.121, A:R.169 Water bridges: A:E.45 Salt bridges: A:E.128

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vazquez, M.L. et al., Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. J. Med. Chem. (2018)

Release Date

2018-01-17

Peptides

Tyrosine-protein kinase JAK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK1

Related Entries With Identical Sequence